Gironi M i współpracownicy. A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. „Multiple Sclerosis”. 14 (8), s. 1076-1083, IX 2008. DOI: 10.1177/1352458508095828. PMID: 18728058.Sprawdź autora:1.
Gironi M, Furlan R, Rovaris M, Comi G, Filippi M, Panerai AE, Sacerdote P. Beta endorphin concentrations in PBMC of patients with different clinical phenotypes of multiple sclerosis. „J Neurol Neurosurg Psychiatry”. 74 (4), s. 495-7, IV 2003. DOI: 10.1177/1352458508095828. PMID: 12640071.Sprawdź autora:1.
nih.gov
ncbi.nlm.nih.gov
Gironi M i współpracownicy. A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. „Multiple Sclerosis”. 14 (8), s. 1076-1083, IX 2008. DOI: 10.1177/1352458508095828. PMID: 18728058.Sprawdź autora:1.
D.A. Weigent, J.E. Blalock. Associations between the neuroendocrine and immune systems. „Journal of Leukocyte Biology”. 58 (2), s. 137-150, VIII 2005. PMID: 7643009.
Gironi M, Furlan R, Rovaris M, Comi G, Filippi M, Panerai AE, Sacerdote P. Beta endorphin concentrations in PBMC of patients with different clinical phenotypes of multiple sclerosis. „J Neurol Neurosurg Psychiatry”. 74 (4), s. 495-7, IV 2003. DOI: 10.1177/1352458508095828. PMID: 12640071.Sprawdź autora:1.